Skip to main content

Table 4 Antimicrobial activity of B. strigosa extracts

From: UPLC–ESI–QTOF–MS profiling, antioxidant, antidiabetic, antibacterial, anti-inflammatory, antiproliferative activities and in silico molecular docking analysis of Barleria strigosa

Samples

MIC (mg/mL)

MBC (mg/mL)

 

LM

VP

PA

SA

EC

LM

VP

PA

SA

EC

BSTR

0.16a

0.16a

0.08a

0.31

0.31a

0.31a

0.31a

0.08a

0.62a

0.62a

LSB

0.62b

0.31b

0.16b

0.31

0.62b

1.25b

0.62b

0.31b

1.25b

1.25b

  1. LM Listeria monocytogenes F2365, VP Vibrio parahaemolyticus PSU.SCB.16S.14, PA Pseudomonas aeruginosa PSU.SCB.16S.11, SA Staphylococcus aureus DMST 4745, Escherichia coli DMST 4212., MIC minimum inhibitory concentration, MBC minimum bactericidal concentration
  2. Data are expressed as mean ± SD (n = 3) and analyzed via one-way ANOVA with Dunnett’s test
  3. Different lowercase superscripts within the same column indicate significant difference at p < 0.05